Product
BIVV009
2 clinical trials
5 indications
Indication
PurpuraIndication
ThrombocytopeniaIndication
IdiopathicIndication
Agglutinin DiseaseIndication
Common coldClinical trial
A Phase 1 Safety, Tolerability, and Pharmacokinetics & Pharmacodynamics Study of Multiple- Dose BIVV009 in Patients With Chronic Immune Thrombocytopenia (ITP)Status: Completed, Estimated PCD: 2021-02-16
Clinical trial
A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood TransfusionStatus: Completed, Estimated PCD: 2021-10-05